Style | Citing Format |
---|---|
MLA | Fathi F, et al.. "Regulatory T-Cells and Their Impacts on Cytokine Profile of End-Stage Renal Disease Patients Suffering From Systemic Lupus Erythematosus." International Journal of Immunopathology and Pharmacology, vol. 33, no. , 2019, pp. -. |
APA | Fathi F, Atapour A, Eskandari N, Keyhanmehr N, Hafezi H, Mohammadi S, Motedayyen H (2019). Regulatory T-Cells and Their Impacts on Cytokine Profile of End-Stage Renal Disease Patients Suffering From Systemic Lupus Erythematosus. International Journal of Immunopathology and Pharmacology, 33(), -. |
Chicago | Fathi F, Atapour A, Eskandari N, Keyhanmehr N, Hafezi H, Mohammadi S, Motedayyen H. "Regulatory T-Cells and Their Impacts on Cytokine Profile of End-Stage Renal Disease Patients Suffering From Systemic Lupus Erythematosus." International Journal of Immunopathology and Pharmacology 33, no. (2019): -. |
Harvard | Fathi F et al. (2019) 'Regulatory T-Cells and Their Impacts on Cytokine Profile of End-Stage Renal Disease Patients Suffering From Systemic Lupus Erythematosus', International Journal of Immunopathology and Pharmacology, 33(), pp. -. |
Vancouver | Fathi F, Atapour A, Eskandari N, Keyhanmehr N, Hafezi H, Mohammadi S, et al.. Regulatory T-Cells and Their Impacts on Cytokine Profile of End-Stage Renal Disease Patients Suffering From Systemic Lupus Erythematosus. International Journal of Immunopathology and Pharmacology. 2019;33():-. |
BibTex | @article{ author = {Fathi F and Atapour A and Eskandari N and Keyhanmehr N and Hafezi H and Mohammadi S and Motedayyen H}, title = {Regulatory T-Cells and Their Impacts on Cytokine Profile of End-Stage Renal Disease Patients Suffering From Systemic Lupus Erythematosus}, journal = {International Journal of Immunopathology and Pharmacology}, volume = {33}, number = {}, pages = {-}, year = {2019} } |
RIS | TY - JOUR AU - Fathi F AU - Atapour A AU - Eskandari N AU - Keyhanmehr N AU - Hafezi H AU - Mohammadi S AU - Motedayyen H TI - Regulatory T-Cells and Their Impacts on Cytokine Profile of End-Stage Renal Disease Patients Suffering From Systemic Lupus Erythematosus JO - International Journal of Immunopathology and Pharmacology VL - 33 IS - SP - EP - PY - 2019 ER - |